China Meheco Co Ltd (600056) - Net Assets
Based on the latest financial reports, China Meheco Co Ltd (600056) has net assets worth CN¥14.60 Billion CNY (≈ $2.14 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥37.48 Billion ≈ $5.48 Billion USD) and total liabilities (CN¥22.88 Billion ≈ $3.35 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 600056 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥14.60 Billion |
| % of Total Assets | 38.96% |
| Annual Growth Rate | 17.9% |
| 5-Year Change | 14.82% |
| 10-Year Change | 86.95% |
| Growth Volatility | 42.85 |
China Meheco Co Ltd - Net Assets Trend (1994–2025)
This chart illustrates how China Meheco Co Ltd's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of China Meheco Co Ltd to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for China Meheco Co Ltd (1994–2025)
The table below shows the annual net assets of China Meheco Co Ltd from 1994 to 2025. For live valuation and market cap data, see 600056 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥14.36 Billion ≈ $2.10 Billion |
+1.79% |
| 2024-12-31 | CN¥14.11 Billion ≈ $2.06 Billion |
+1.61% |
| 2023-12-31 | CN¥13.89 Billion ≈ $2.03 Billion |
+5.42% |
| 2022-12-31 | CN¥13.17 Billion ≈ $1.93 Billion |
+5.31% |
| 2021-12-31 | CN¥12.51 Billion ≈ $1.83 Billion |
+2.38% |
| 2020-12-31 | CN¥12.22 Billion ≈ $1.79 Billion |
+10.97% |
| 2019-12-31 | CN¥11.01 Billion ≈ $1.61 Billion |
+8.62% |
| 2018-12-31 | CN¥10.14 Billion ≈ $1.48 Billion |
+14.10% |
| 2017-12-31 | CN¥8.88 Billion ≈ $1.30 Billion |
+15.63% |
| 2016-12-31 | CN¥7.68 Billion ≈ $1.12 Billion |
+27.23% |
| 2015-12-31 | CN¥6.04 Billion ≈ $883.69 Million |
+10.17% |
| 2014-12-31 | CN¥5.48 Billion ≈ $802.14 Million |
+41.53% |
| 2013-12-31 | CN¥3.87 Billion ≈ $566.76 Million |
+68.14% |
| 2012-12-31 | CN¥2.30 Billion ≈ $337.08 Million |
+20.44% |
| 2011-12-31 | CN¥1.91 Billion ≈ $279.87 Million |
+18.86% |
| 2010-12-31 | CN¥1.61 Billion ≈ $235.47 Million |
-0.52% |
| 2009-12-31 | CN¥1.62 Billion ≈ $236.70 Million |
+37.32% |
| 2008-12-31 | CN¥1.18 Billion ≈ $172.37 Million |
-23.63% |
| 2007-12-31 | CN¥1.54 Billion ≈ $225.72 Million |
+115.26% |
| 2006-12-31 | CN¥716.57 Million ≈ $104.86 Million |
-6.54% |
| 2005-12-31 | CN¥766.70 Million ≈ $112.19 Million |
+15.89% |
| 2004-12-31 | CN¥661.58 Million ≈ $96.81 Million |
+5.64% |
| 2003-12-31 | CN¥626.26 Million ≈ $91.64 Million |
+7.35% |
| 2002-12-31 | CN¥583.37 Million ≈ $85.37 Million |
+6.05% |
| 2001-12-31 | CN¥550.11 Million ≈ $80.50 Million |
+7.31% |
| 2000-12-31 | CN¥512.65 Million ≈ $75.02 Million |
+34.78% |
| 1999-12-31 | CN¥380.35 Million ≈ $55.66 Million |
-0.45% |
| 1998-12-31 | CN¥382.07 Million ≈ $55.91 Million |
-1.07% |
| 1997-12-31 | CN¥386.19 Million ≈ $56.51 Million |
+215.72% |
| 1996-12-31 | CN¥122.32 Million ≈ $17.90 Million |
+19.59% |
| 1995-12-31 | CN¥102.28 Million ≈ $14.97 Million |
+17.23% |
| 1994-12-31 | CN¥87.25 Million ≈ $12.77 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to China Meheco Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1575063.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥8.08 Billion | 68.27% |
| Other Components | CN¥3.76 Billion | 31.73% |
| Total Equity | CN¥11.84 Billion | 100.00% |
China Meheco Co Ltd Competitors by Market Cap
The table below lists competitors of China Meheco Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NV Bekaert SA
BR:BEKB
|
$1.99 Billion |
|
Innospec Inc
NASDAQ:IOSP
|
$1.99 Billion |
|
Nations Technologies Inc
SHE:300077
|
$1.99 Billion |
|
BlackRock Science and Technology Trust II
NYSE:BSTZ
|
$1.99 Billion |
|
Guangdong Tonze Electric Co Ltd
SHE:002759
|
$1.99 Billion |
|
RLX TECH. SP.ADR/1 CL.A
F:3CM
|
$1.99 Billion |
|
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
|
$1.99 Billion |
|
Jonjee Hi-tech Industrial and Commercial Holding Co Ltd
SHG:600872
|
$1.99 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in China Meheco Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 11,820,516,000 to 11,835,948,720, a change of 15,432,720 (0.1%).
- Net income of 473,229,055 contributed positively to equity growth.
- Dividend payments of 303,514,125 reduced retained earnings.
- Other factors decreased equity by 154,282,210.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥473.23 Million | +4.0% |
| Dividends Paid | CN¥303.51 Million | -2.56% |
| Other Changes | CN¥-154.28 Million | -1.3% |
| Total Change | CN¥- | 0.13% |
Book Value vs Market Value Analysis
This analysis compares China Meheco Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.15x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 64.79x to 1.15x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-12-31 | CN¥0.14 | CN¥9.09 | x |
| 1995-12-31 | CN¥0.16 | CN¥9.09 | x |
| 1996-12-31 | CN¥0.20 | CN¥9.09 | x |
| 1997-12-31 | CN¥0.62 | CN¥9.09 | x |
| 1998-12-31 | CN¥0.61 | CN¥9.09 | x |
| 1999-12-31 | CN¥0.61 | CN¥9.09 | x |
| 2000-12-31 | CN¥0.82 | CN¥9.09 | x |
| 2001-12-31 | CN¥0.88 | CN¥9.09 | x |
| 2002-12-31 | CN¥0.94 | CN¥9.09 | x |
| 2003-12-31 | CN¥1.00 | CN¥9.09 | x |
| 2004-12-31 | CN¥0.98 | CN¥9.09 | x |
| 2005-12-31 | CN¥1.10 | CN¥9.09 | x |
| 2006-12-31 | CN¥0.72 | CN¥9.09 | x |
| 2007-12-31 | CN¥1.64 | CN¥9.09 | x |
| 2008-12-31 | CN¥1.22 | CN¥9.09 | x |
| 2009-12-31 | CN¥1.68 | CN¥9.09 | x |
| 2010-12-31 | CN¥1.67 | CN¥9.09 | x |
| 2011-12-31 | CN¥1.91 | CN¥9.09 | x |
| 2012-12-31 | CN¥1.56 | CN¥9.09 | x |
| 2013-12-31 | CN¥2.68 | CN¥9.09 | x |
| 2014-12-31 | CN¥3.60 | CN¥9.09 | x |
| 2015-12-31 | CN¥3.81 | CN¥9.09 | x |
| 2016-12-31 | CN¥4.79 | CN¥9.09 | x |
| 2017-12-31 | CN¥7.26 | CN¥9.09 | x |
| 2018-12-31 | CN¥5.65 | CN¥9.09 | x |
| 2019-12-31 | CN¥8.42 | CN¥9.09 | x |
| 2020-12-31 | CN¥9.36 | CN¥9.09 | x |
| 2021-12-31 | CN¥6.86 | CN¥9.09 | x |
| 2022-12-31 | CN¥7.23 | CN¥9.09 | x |
| 2023-12-31 | CN¥7.73 | CN¥9.09 | x |
| 2024-12-31 | CN¥7.90 | CN¥9.09 | x |
| 2025-12-31 | CN¥7.91 | CN¥9.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently China Meheco Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.34%
- • Asset Turnover: 0.96x
- • Equity Multiplier: 3.12x
- Recent ROE (4.00%) is below the historical average (13.95%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | 40.64% | 2.73% | 4.18x | 3.56x | CN¥26.73 Million |
| 1995 | 43.06% | 3.56% | 4.09x | 2.96x | CN¥33.82 Million |
| 1996 | 38.37% | 2.06% | 6.08x | 3.06x | CN¥34.70 Million |
| 1997 | 16.02% | 3.16% | 2.59x | 1.96x | CN¥23.23 Million |
| 1998 | 11.69% | 2.56% | 2.26x | 2.02x | CN¥6.44 Million |
| 1999 | 8.32% | 2.15% | 1.62x | 2.39x | CN¥-6.40 Million |
| 2000 | 6.29% | 2.30% | 1.25x | 2.19x | CN¥-19.01 Million |
| 2001 | 8.91% | 1.97% | 2.06x | 2.19x | CN¥-5.98 Million |
| 2002 | 7.75% | 1.96% | 2.30x | 1.72x | CN¥-13.09 Million |
| 2003 | 6.79% | 1.59% | 2.90x | 1.47x | CN¥-20.05 Million |
| 2004 | 1.07% | 0.30% | 2.24x | 1.59x | CN¥-54.48 Million |
| 2005 | 10.62% | 3.76% | 1.15x | 2.45x | CN¥4.25 Million |
| 2006 | 11.51% | 2.68% | 1.56x | 2.75x | CN¥9.48 Million |
| 2007 | 16.38% | 9.49% | 0.91x | 1.90x | CN¥91.52 Million |
| 2008 | 15.39% | 5.29% | 1.26x | 2.31x | CN¥57.10 Million |
| 2009 | 12.91% | 3.95% | 0.88x | 3.73x | CN¥42.68 Million |
| 2010 | 13.40% | 3.11% | 1.20x | 3.60x | CN¥49.41 Million |
| 2011 | 16.18% | 3.70% | 1.18x | 3.71x | CN¥102.71 Million |
| 2012 | 20.80% | 3.07% | 1.66x | 4.09x | CN¥216.03 Million |
| 2013 | 14.10% | 3.27% | 1.16x | 3.72x | CN¥141.07 Million |
| 2014 | 11.06% | 3.08% | 1.26x | 2.85x | CN¥52.58 Million |
| 2015 | 11.38% | 2.99% | 1.27x | 2.99x | CN¥74.42 Million |
| 2016 | 13.81% | 3.66% | 1.33x | 2.84x | CN¥261.80 Million |
| 2017 | 16.93% | 4.33% | 1.43x | 2.73x | CN¥537.46 Million |
| 2018 | 18.27% | 4.98% | 1.22x | 3.00x | CN¥699.35 Million |
| 2019 | 10.91% | 2.78% | 1.18x | 3.32x | CN¥81.86 Million |
| 2020 | 13.10% | 3.33% | 1.18x | 3.32x | CN¥310.12 Million |
| 2021 | 6.31% | 1.79% | 1.16x | 3.03x | CN¥-378.74 Million |
| 2022 | 6.80% | 1.96% | 1.05x | 3.32x | CN¥-345.98 Million |
| 2023 | 9.07% | 2.70% | 1.04x | 3.24x | CN¥-108.02 Million |
| 2024 | 4.53% | 1.57% | 0.97x | 2.98x | CN¥-646.58 Million |
| 2025 | 4.00% | 1.34% | 0.96x | 3.12x | CN¥-710.37 Million |
Industry Comparison
This section compares China Meheco Co Ltd's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $9,249,059,974
- Average return on equity (ROE) among peers: 10.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| China Meheco Co Ltd (600056) | CN¥14.60 Billion | 40.64% | 1.57x | $1.99 Billion |
| China National Accord Medicines Corp Ltd (000028) | $472.90 Million | 15.34% | 4.67x | $1.60 Billion |
| Shenzhen Glory Medical Co Ltd (002551) | $3.45 Billion | 1.29% | 0.44x | $348.90 Million |
| Shandong Realcan Pharmaceutical Co Ltd (002589) | $9.69 Billion | 1.35% | 1.72x | $581.29 Million |
| China National Accord Medicines Corp Ltd (200028) | $334.70 Million | 1.47% | 2.14x | $125.51 Million |
| Qingdao Baheal Medical INC. (301015) | $2.60 Billion | 26.55% | 1.73x | $1.64 Billion |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) | $41.12 Billion | 7.25% | 1.05x | $4.27 Billion |
| China National Medicines Corp Ltd (600511) | $10.61 Billion | 13.23% | 1.03x | $3.00 Billion |
| Liaoning Cheng Da Co Ltd (600739) | $6.87 Billion | 19.53% | 0.22x | $2.26 Billion |
| Jointown Pharmaceutical Group Co Ltd (600998) | $8.09 Billion | 6.93% | 1.98x | $3.56 Billion |
About China Meheco Co Ltd
China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and en… Read more